| Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis F Conforti, L Pala, I Sala, C Oriecuia, T De Pas, C Specchia, R Graffeo, ... Bmj 375, 2021 | 91 | 2021 |
| Nonalcoholic fatty liver disease and advanced fibrosis in US adults across blood pressure categories S Ciardullo, T Monti, I Sala, G Grassi, G Mancia, G Perseghin Hypertension 76 (2), 562-568, 2020 | 50 | 2020 |
| Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial F Conforti, PA Zucali, L Pala, C Catania, V Bagnardi, I Sala, P Della Vigna, ... The Lancet Oncology 23 (10), 1287-1296, 2022 | 29 | 2022 |
| Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005–2016 S Ciardullo, I Sala, G Perseghin Diabetes Research and Clinical Practice 167, 108358, 2020 | 24 | 2020 |
| Characteristics and clinical implications of carbapenemase-producing Klebsiella pneumoniae colonization and infection, Italy M Rossi, L Chatenoud, F Gona, I Sala, G Nattino, A D'Antonio, D Castelli, ... Emerging infectious diseases 27 (5), 1416, 2021 | 14 | 2021 |
| Association of anticancer immune checkpoint inhibitors with patient-reported outcomes assessed in randomized clinical trials: a systematic review and meta-analysis L Pala, I Sala, C Oriecuia, T De Pas, P Queirolo, C Specchia, ... JAMA Network Open 5 (8), e2226252-e2226252, 2022 | 12 | 2022 |
| Factors associated with the arrival of smartphone-activated first responders before the emergency medical services in out-of-hospital cardiac arrest dispatch L Gamberini, D Del Giudice, S Saltalamacchia, B Taylor, I Sala, D Allegri, ... Resuscitation 185, 109746, 2023 | 11 | 2023 |
| Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study F Conforti, A Gronchi, N Penel, RL Jones, JM Broto, I Sala, V Bagnardi, ... European Journal of Cancer 171, 183-192, 2022 | 11 | 2022 |
| Sodium nitroprusside in acute heart failure: a multicenter historic cohort study L Garatti, S Frea, PP Bocchino, F Angelini, M Cingolani, A Sacco, ... International Journal of Cardiology 369, 37-44, 2022 | 10 | 2022 |
| Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized … L Pala, T De Pas, E Pagan, I Sala, C Catania, E Zattarin, P Arnone, ... The Breast 69, 258-264, 2023 | 3 | 2023 |
| Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials C Oriecuia, D Tomasoni, I Sala, GB Bonfioli, M Adamo, C Gussago, ... European Heart Journal-Cardiovascular Pharmacotherapy 10 (2), 147-157, 2024 | 2 | 2024 |
| Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland K Ribi, E Pagan, I Sala, M Ruggeri, N Bianco, EO Bucci, R Graffeo, ... Journal of Cancer Survivorship 17 (6), 1847-1858, 2023 | 1 | 2023 |
| Role of microsatellite instability and Her2 positivity in locally advanced Esophago-gastric cancer patients treated with peri-operative chemotherapy L Gervaso, L Bottiglieri, MI Meneses-Medina, S Pellicori, R Biffi, ... Clinical and Translational Oncology 25 (11), 3287-3295, 2023 | 1 | 2023 |
| SARS-CoV-2 Infection in San Patrignano, the Largest European Drug Rehabilitation Community I Sala, CM Jarach, V Bagnardi, MS Cattaruzza, M Morri, P Ottogalli, ... International Journal of Environmental Research and Public Health 20 (3), 2136, 2023 | 1 | 2023 |
| Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study F Magnoni, B Bianchi, E Pagan, G Corso, I Sala, V Bagnardi, S Claudia, ... Breast Cancer Research and Treatment, 1-15, 2024 | | 2024 |
| Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis L Pala, E Pagan, I Sala, C Oriecuia, M Oliari, T De Pas, C Specchia, ... eClinicalMedicine 73, 2024 | | 2024 |
| Heterogeneity of treatment effect on patients’ long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer. L Pala, I Sala, E Pagan, T De Pas, E Zattarin, C Catania, E Cocorocchio, ... The Breast 73, 103672, 2024 | | 2024 |
| Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis I Sala, E Pagan, L Pala, C Oriecuia, M Musca, C Specchia, T De Pas, ... Frontiers in Immunology 15, 1340979, 2024 | | 2024 |
| Questionnaires May Help Pulmonologists for Referral of Patients With IPF to a Holistic Approach P Faverio, I Sala, N Anzani, U Zanini, V Bonfanti, M Falzone, A Biffi, ... Archivos de bronconeumologia, 2024 | | 2024 |
| Corrigendum to'Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study'[Eur J Cancer 171 (2022) 183-192] F Conforti, A Gronchi, N Penel, RL Jones, JM Broto, I Sala, V Bagnardi, ... European journal of cancer (Oxford, England: 1990) 184, 197-198, 2023 | | 2023 |
